The changing face of pharma in the precision era

Natasha Cowan|6th September 2019

Nancy Brandt is not your typical medical information specialist. While medical affairs teams are usually focused on developing scientific communications about a product or service for healthcare professionals, she has been tasked with preparing a top 20 biopharma company for the future of precision medicine.

For pharma, it’s clear the future lies in making the right partnerships. Precision medicine equates understanding the patient’s molecular makeup and using this information and other clinical data to find targeted treatments. However, right now the policies and regulations are still being written. New stakeholders are entering the fray and bringing with them novel technologies that can improve patient outcomes.

We are on the brink of a new way of practising medicine and pharmaceutical companies have the opportunity to shape this future, but this hinges on collaborating with the right people and listening to what the complex network of stakeholders are asking of them.

This means moving away from a product-specific way of thinking to develop a deep insight into how society is changing as precision medicines emerge. As a result, Nancy is immersed in understanding the patient journey and developing agile ways of working to ensure the organisation stays one step ahead of novel developments. Armed with this information, she can then develop partnerships that will fuel innovative communications for the 21st-century patient and the complex stakeholder network, from doctors to policymakers.

Here, she reveals how she is embracing this new way of working and the lessons she has learned along the way.

In the precision medicine era, the line between products and services is blurred

Amit Sheinholtz and Ilektra Safari|27th August 2020

Precision and personalised medicines are more than products, they are services in their own right. So, how should pharma approach this uncharted territory to ensure targeted therapies work for patients?

read more

Understanding COVID-19 and varying responses across the globe

Lauren Fernandes|28th July 2020

At the beginning of the COVID-19 Pandemic, Senior Account Executive Lauren Fernandes took a course at the London School of Hygiene and Tropical Medicine to better understand how the global response to the virus and to ensure we were best positioned to serve our clients during this challenging time. She shares the key learnings and why understanding the epidemiology of the disease is integral for fighting it.

read more

Delivering impactful customer engagements in COVID-19

Blue Latitude Health|14th July 2020

Blue Latitude Health, and our parent company Fishawack Health, have developed exclusive intellectual property, processes and tools to ensure you’re engaging customers in the right way. View our service one-pagers below to find out how we can help solve your challenges whether you’re in a medical, brand, portfolio or an above brand role.

read more